Skip to content

APOTHEEK VANCLOOSTER: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK VANCLOOSTER

BE 0475.240.909
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€273,721
2024 · €299,027-€25,307
Equity
€1.4m
2024 · €1.2m+€132,721
Cash
€335,053
2024 · €152,157+€182,895
Balance sheet total
€1.5m
2024 · €1.3m+€160,551

Largest movements

2024 to 2025
Assets
  • Cash +€182,895

    up €182,895 (+120%), from €152,157 to €335,053

    mainly Net result for the year (+€273,721) and Current investments (+€31,398)

  • Current investments -€31,398

    down €31,398 (-3.9%), from €814,148 to €782,750

  • Receivables within one year +€26,400

    up €26,400 (+21.2%), from €124,447 to €150,847

    of which Trade receivables: +€26,710

  • Tangible fixed assets -€17,929

    down €17,929 (-42.0%), from €42,644 to €24,715

    of which Furniture and vehicles: -€15,407

Equity and liabilities
  • Reserves +€132,721

    up €132,721 (+10.9%), from €1.2m to €1.4m

Income statement
  • Financial income -€31,655

    down €31,655 (-60.0%), from €52,773 to €21,119

  • Taxes -€8,360

    down €8,360 (-9.3%), from €89,993 to €81,633

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €299,027
Gross operating margin +€302
Staff costs -€812
Depreciation +€127
Other operating charges +€119
Financial income -€31,655
Financial charges -€1,749
Taxes +€8,360
Result 2025 €273,721
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€292,498
Investment +€31,398
Financing -€141,000
Cash 2024 €152,157
Net result for the year +€273,721
Depreciation +€17,929
Stocks and contracts -€1,734
Receivables within one year -€26,400
Deferred charges and accrued income +€1,152
Trade debts +€12,240
Tax, wage and social debts +€12,335
Other debts +€2,975
Accrued charges and deferred income +€280
Current investments +€31,398
Contributions, distributions and other -€141,000
Cash 2025 €335,053
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,319,451 €1,480,002 +€160,551 +12.2%
Fixed assets 21/28 €42,644 €24,715 -€17,929 -42.0%
Tangible fixed assets 22/27 €42,644 €24,715 -€17,929 -42.0%
Land and buildings 22 €5,430 €3,857 -€1,573 -29.0%
Plant, machinery and equipment 23 €2,276 €1,327 -€949 -41.7%
Furniture and vehicles 24 €34,938 €19,531 -€15,407 -44.1%
Current assets 29/58 €1,276,807 €1,455,287 +€178,481 +14.0%
Stocks and contracts in progress 3 €162,999 €164,733 +€1,734 +1.1%
Stocks 30/36 €162,999 €164,733 +€1,734 +1.1%
Amounts receivable within one year 40/41 €124,447 €150,847 +€26,400 +21.2%
Trade receivables 40 €124,000 €150,710 +€26,710 +21.5%
Other amounts receivable 41 €447 €137 -€310 -69.4%
Current investments 50/53 €814,148 €782,750 -€31,398 -3.9%
Cash at bank and in hand 54/58 €152,157 €335,053 +€182,895 +120%
Deferred charges and accrued income 490/1 €23,056 €21,904 -€1,152 -5.0%
Total equity and liabilities 10/49 €1,319,451 €1,480,002 +€160,551 +12.2%
Equity 10/15 €1,241,276 €1,373,996 +€132,721 +10.7%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,222,676 €1,355,396 +€132,721 +10.9%
Distributable reserves 133 €1,222,676 €1,355,396 +€132,721 +10.9%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €78,175 €106,006 +€27,831 +35.6%
Amounts payable within one year 42/48 €75,383 €102,934 +€27,551 +36.5%
Trade debts 44 €56,669 €68,909 +€12,240 +21.6%
Suppliers 440/4 €56,669 €68,909 +€12,240 +21.6%
Taxes, remuneration and social security 45 €17,584 €29,920 +€12,335 +70.2%
Taxes 450/3 €11,410 €23,683 +€12,273 +108%
Remuneration and social security 454/9 €6,174 €6,237 +€62 +1.0%
Other amounts payable 47/48 €1,130 €4,105 +€2,975 +263%
Accrued charges and deferred income 492/3 €2,792 €3,072 +€280 +10.0%
Remuneration, social security and pensions 62 €14,751 €15,563 +€812 +5.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,057 €17,929 -€127 -0.7%
Other operating charges 640/8 €2,523 €2,404 -€119 -4.7%
Gross operating margin 9900 €377,503 €377,805 +€302 +0.1%
Operating profit (loss) 9901 €342,172 €341,908 -€264 -0.1%
Financial income 75/76B €52,773 €21,119 -€31,655 -60.0%
Recurring financial income 75 €52,773 €21,119 -€31,655 -60.0%
Financial charges 65/66B €5,925 €7,674 +€1,749 +29.5%
Recurring financial charges 65 €5,925 €7,674 +€1,749 +29.5%
Non-recurring financial charges 66B €0 - =
Profit (loss) for the period before taxes 9903 €389,020 €355,353 -€33,667 -8.7%
Income taxes 67/77 €89,993 €81,633 -€8,360 -9.3%
Profit (loss) for the period 9904 €299,027 €273,721 -€25,307 -8.5%
Profit (loss) for the period to be appropriated 9905 €299,027 €273,721 -€25,307 -8.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.